ArticleHuman genomics2026
Naming the alpha-2-macroglobulin gene family across vertebrates.
Article in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The HUGO Gene Nomenclature Committee (HGNC) assigns unique symbols and names to human genes and its sister project, the Vertebrate Gene Nomenclature Committee (VGNC), names genes across selected vertebrates (chimp, macaque, horse, cattle, pig, dog, cat) in line with their human orthologs. The A2M gene family, a subfamily of the thioester-containing protein (TEP) superfamily, is well conserved across vertebrates and several members of this family have already been characterized as non-specific peptidase inhibitors. Chicken ovostatin, originally termed “ovomacroglobulin”, is an A2M family member that was first identified as being one of the most abundant proteins found in egg white. Two uncharacterized ovostatin homologs have also been reported in human. We wanted to assign standardized nomenclature to the multiple members of the A2M family across a wide range of vertebrate species, to capture the variation within this complex gene family. We constructed a maximum likelihood phylogenetic tree based on a multiple alignment of A2M protein sequences to help assign new nomenclature to previously unnamed A2M family genes, including the ovostatins, in human and across selected vertebrate species. This resulted in the naming of 4 human A2M family pseudogenes and 14 protein coding genes and 4 pseudogenes across VGNC species. An additional 48 genes were also named in model organisms (mouse, rat, xenopus, zebrafish, chicken) by their nomenclature committees based on this phylogenetic analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.